Institutional Ownership Lyra Therapeutics, Inc. (LYRA)
This table provides information about the institutional ownership of Lyra Therapeutics, Inc. (LYRA). We have compiled data on the 61 institutions that hold shares in the stock, with a total of 32.2 Million shares, which have been reported (via 13F filing form) to have a value of $5.48 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Perceptive Advisors LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
12,757,562
shares
|
$2.3 Million
0.09% of portfolio
|
Q2 2023
Added 39.48%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2024 Q3 2024 |
4,772,816
shares
|
$859,106
0.0% of portfolio
|
Q2 2024
Added 10.0%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
2,829,978
shares
|
$509,396
0.0% of portfolio
|
Q2 2024
Added 1762.82%
|
|
|
Samsara Bio Capital, LLC
Palo Alto, CA |
Nov 14, 2024 Q3 2024 |
2,780,261
shares
|
$500,446
0.42% of portfolio
|
Q2 2023
Added 56.44%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
1,779,263
shares
|
$320,267
0.0% of portfolio
|
Q3 2024
Added 2.79%
|
|
|
Ikarian Capital, LLC
Dallas, TX |
Nov 14, 2024 Q3 2024 |
1,056,829
shares
|
$190,229
0.05% of portfolio
|
Q1 2024
Reduced 15.75%
|
|
|
Sei Investments CO
Oaks, PA |
Nov 12, 2024 Q3 2024 |
997,782
shares
|
$179,600
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
768,388
shares
|
$138,309
0.0% of portfolio
|
Q3 2024
Added 1.76%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
652,381
shares
|
$117,428
0.0% of portfolio
|
Q3 2024
Reduced 19.63%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
547,339
shares
|
$98,521
0.0% of portfolio
|
Q3 2024
Added 2144.02%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
488,720
shares
|
$87,969
0.0% of portfolio
|
Q3 2024
Added 88.1%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Nov 14, 2024 Q3 2024 |
460,300
shares
|
$82,854
0.0% of portfolio
|
Q3 2024
Reduced 32.47%
|
|
|
Two Sigma Investments, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
282,547
shares
|
$50,858
0.0% of portfolio
|
Q3 2024
Reduced 42.44%
|
|
|
Everhart Financial Group, Inc.
|
Nov 04, 2024 Q3 2024 |
252,708
shares
|
$45,487
0.01% of portfolio
|
Q3 2024
New holding
|
|
|
Boothbay Fund Management, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
232,670
shares
|
$41,880
0.0% of portfolio
|
Q1 2024
Reduced 6.91%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 13, 2024 Q3 2024 |
183,284
shares
|
$32,991
0.0% of portfolio
|
Q3 2024
Added 118.56%
|
|
|
Exodus Point Capital Management, LP
New York, NY |
Nov 12, 2024 Q3 2024 |
159,238
shares
|
$28,662
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
New York State Common Retirement Fund
|
Oct 28, 2024 Q3 2024 |
154,800
shares
|
$27,864
0.0% of portfolio
|
Q3 2024
Reduced 59.57%
|
|
|
Bank Of Montreal
Toronto, A6 |
Nov 13, 2024 Q3 2024 |
119,379
shares
|
$21,488
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 12, 2024 Q3 2024 |
111,609
shares
|
$20,089
0.0% of portfolio
|
Q2 2024
New holding
|
|
|
Acadian Asset Management LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
110,493
shares
|
$19,888
0.0% of portfolio
|
Q3 2024
Reduced 88.79%
|
|
|
Beacon Pointe Advisors, LLC
Newport Beach, CA |
Nov 14, 2024 Q3 2024 |
77,112
shares
|
$13,880
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Barclays PLC
London, X0 |
Nov 19, 2024 Q3 2024 |
63,303
shares
|
$11,394
0.0% of portfolio
|
Q3 2024
Added 281.25%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 08, 2024 Q3 2024 |
59,761
shares
|
$10,756
0.0% of portfolio
|
Q3 2024
Added 189.27%
|
|
|
Jane Street Group, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
54,601
shares
|
$9,828
0.0% of portfolio
|
Q3 2024
Added 27.94%
|